Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Rakesh Ojha"'
Publikováno v:
Asian Journal of Pharmaceutical and Clinical Research. 10:376
Objectives: No long-term clinical efficacy and safety study of resveratrol as adjuvant therapy along with gold standard therapy has been conductedin patients with essential hypertension. The aim of this study was to investigate the efficacy and safet
Publikováno v:
Blood. 106:5384-5384
The major cause of non-relapse transplant related mortality (TRM) in UCBT continues to be infectious, with blood stream infections (BSI) constituting the majority of these events. However, CMV antigenemia and BK virus associated late onset hemorrhagi
Autor:
Nasser Janbay, Rakesh Ojha, Pradeep Manna, Reyad Mohsen, N. Visweshar, S. Stives, Rajneesh Nath, Devinderdal Randhawa, Howard Benn, Albish Amin
Publikováno v:
Blood. 104:5110-5110
Background. Hemorrhagic cystitis (HC) following stem cell transplant (SCT) is classified into two types, based on causes and time of appearance. Early-onset HC occurs within 48 hours of preparative regimen, and is thought to be a complication of high